General Archive
-
News releasesThird global Longitude Prize to be launched in 2025 focusing on ALS
A LifeArc-funded prize to incentivise the use of AI and machine-learning approaches in drug discovery for ALS, a form of…
-
News releasesLifeArc appoints Chief Medical Officer to deliver more scientific breakthroughs for patients
LifeArc has appointed healthcare leader and pharmaceutical industry expert, Dr Jonathan Morgan, as the charity’s first Chief Medical Officer.. Jonathan…
-
News releases£2.7m infectious disease fund to boost rapid testing, drug trials and innovative specimen storage
Rapid diagnostic tests for deadly global viral threats, repurposing antibiotics to tackle neglected tropical diseases and a potential solution to…
-
News releasesPromising results in clinical trial gives hope to patients with blood disorder
A trial for a cutting-edge cell therapy that could become the first ever treatment for the rare, life-threatening blood disorder…
-
News releases3 steps LifeArc is taking to tackle antimicrobial resistance before it’s too late
Antimicrobial resistance (AMR) is one of the most urgent public health challenges of our time, threatening not only human health…
-
News releases
£76M investment backing into potential MND treatment, underlines benefit of charity funding
Promising new research to develop gene therapy to treat motor neuron disease and other conditions like dementia secures big investment…
-
News releasesTackling antimicrobial resistance: LifeArc partners with the University of Cape Town to launch a new Centre for Translational AMR Research
LifeArc has announced a significant £5 million investment to co-establish a new Centre for Translational AMR Research (CTAR) Programme at…
-
News releasesLifeArc launches UK’s first cystic fibrosis Innovation Hub Network
The UK’s first network of Cystic Fibrosis Lung Health Innovation Hubs is being launched to accelerate the development of new…
-
News releasesGlobal AMR challenge receives a £5m boost to drive diagnostics innovation
PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its second funding round with up to £5 million available to support…
-
News releasesFirst awardees of £3m collaborative Drug Discovery Programme are announced
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has announced the first cohort of awardees of its Collaborative Discovery Programme…
-
News releasesCharities join forces to transform treatment for children with cancer
A pioneering initiative to develop new medicines exclusively for children’s and young people’s cancers, has been launched LifeArc and Cancer…
-
News releasesAI software tool aims to spot early signs of dementia from brain scans during routine appointments
LifeArc is supporting data scientists and clinical researchers who are using brain scans from the entire Scottish population to build…